2026. Synthesis and Characterization of YYGSR-NH2 as a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development. JURNAL FARMASIMED (JFM). 9, 1 (Oct. 2026), 830–841. DOI:https://doi.org/10.35451/jfm.v9i1.3856.